- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Thyroid Related Eye Disease in Hong Kong
Total 859 results
-
Hoffmann-La RocheActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Korea, Republic of, United Kingdom, Japan, Canada, Turkey, Argentina, Australia, Denmark, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Brazil, Hong Kong, Israel, Portugal, Russian Federation, Ta... and more
-
AmgenActive, not recruitingIgG4 Related DiseasePoland, Spain, United States, Argentina, Australia, Canada, China, France, Germany, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Sweden, Turkey, United Kingdom
-
BayerTerminatedMacular DegenerationHong Kong, Korea, Republic of, United States, Canada, Switzerland, Spain, Japan, Italy, Czech Republic, Australia, Austria, Slovakia, Germany, Hungary, Israel, Chile, France, Colombia
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Romania, Mexico, United States, Bulgaria, Germany, Latvia, Lithuania, Guatemala
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Malaysia, Hungary, Belgium, Slovakia, Philippines, Thailand, Hong Kong
-
Santen Inc.CompletedOcular Hypertension | Open-angle GlaucomaUnited States
-
Abbott Diabetes CareCompletedType 2 Diabetes MellitusUnited States
-
VA Office of Research and DevelopmentRecruitingSuvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic StressSleep Initiation and Maintenance Disorders | Stress Disorders, PosttraumaticUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleUnited States, Hong Kong, Taiwan, Spain, Israel, Australia, Austria, Belgium, Brazil, Denmark, Hungary, Peru, Philippines, Poland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedCancerUnited States, Australia
-
TearLab CorporationAbbott Medical Optics; TLC Laser Eye CenterCompleted
-
US Department of Veterans AffairsCompletedType 2 Diabetes MellitusUnited States
-
Abbott Medical OpticsCompletedCataract | AstigmatismUnited States
-
SanofiCompletedType 2 Diabetes MellitusChina, Korea, Republic of, Malaysia, Taiwan
-
ANRS, Emerging Infectious DiseasesNational Institute on Drug Abuse (NIDA)CompletedHIV | Substance Abuse | Hepatitis VirusVietnam
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Spain, United States, Mexico, Russian Federation, Guatemala, United Kingdom, Brazil
-
Outlook Therapeutics, Inc.CompletedAge-related Macular Degeneration | Diabetic Macular Edema | Wet Macular Degeneration | Neovascular Age-related Macular Degeneration | BRVO - Branch Retinal Vein OcclusionUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Poland, Russian Federation, Spain, Sweden, Netherlands, Singapore, Malaysia, France, Croatia, Romania, United Kingdom, Hong Kong
-
Astellas Pharma Korea, Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
Novartis PharmaceuticalsCompletedBehcet DiseaseIndia, Turkey, Spain, Germany, Italy, France, Israel, Greece, Korea, Republic of, Hong Kong, United States, Egypt, Jordan, Singapore, Switzerland, Taiwan, Tunisia
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusTaiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
-
Opthea LimitedRecruitingNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Czechia, Denmark, France, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Latvia, Malaysia, Poland, Spain, Thailand, Ukraine, United Kingdom
-
Johnson & Johnson Surgical Vision, Inc.CompletedCataract | Corneal AstigmatismUnited States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAllergic RhinitisUnited States
-
Hoffmann-La RocheActive, not recruitingMelanoma | Renal Cell Carcinoma | Adult Solid Tumor | Breast Cancer | Head and Neck Neoplasms | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Neuroendocrine Tumors | Lymphoma, Large-Cell, Anaplastic | Cholangiocarcinoma | Papillary Thyroid Cancer | Sarcomas | Salivary Gland Cancers and other conditionsUnited States, China, Korea, Republic of, Australia, Taiwan, France, Spain, United Kingdom, Hong Kong, Belgium, Italy, Germany, Japan, Singapore, Netherlands, Poland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of, Japan, Malaysia, Taiwan, Thailand, Hong Kong
-
OPKO Health, Inc.CompletedBreast Cancer | Bone Neoplasms | Prostate Cancer | Hypocalcemia | Hyperparathyroidism, SecondaryUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan, Malaysia, Taiwan, Korea, Republic of, Hong Kong
-
VA Office of Research and DevelopmentAnalydata, IncRecruiting
-
Taewoong Medical Co., Ltd.CompletedComparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III)Pancreatic Neoplasms | Biliary Obstruction | Biliary NeoplasmsKorea, Republic of
-
Podimetrics, Inc.CompletedFoot Ulcer, DiabeticUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingGlioma | Cholangiocarcinoma | Chondrosarcoma | Any Solid TumorUnited States, Spain, Korea, Republic of, Australia, Japan, Taiwan, France, Singapore, Hong Kong
-
BayerRegeneron PharmaceuticalsCompletedAflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy (FIREFLEYE)Retinopathy of Prematurity (ROP)Spain, Singapore, Hong Kong, Korea, Republic of, Malaysia, Japan, Taiwan, Sweden, Portugal, Belgium, Argentina, Bulgaria, Italy, Austria, Brazil, Czechia, Greece, Hungary, Israel, Netherlands, Poland, Romania, Russian Federation, Slov... and more
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Italy, Hong Kong, Romania, Greece, United States, Mexico, Serbia, Russian Federation
-
Zenas BioPharma (USA), LLCRecruitingIgG4 Related DiseaseUnited States, Korea, Republic of, Spain, China, Japan, France, Mexico, Poland, Taiwan, Hungary, Italy, Germany, United Kingdom, Argentina, Netherlands, Turkey, Hong Kong, Sweden, Canada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTaiwan, Korea, Republic of, South Africa, Hong Kong, Brazil, China, Ukraine
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Korea, Republic of, Taiwan
-
XOMA (US) LLCInstitut de Recherches Internationales ServierTerminatedUveitisUnited States, France, Germany, Poland, United Kingdom, China, Spain, Mexico, Portugal, Turkey, Israel, Korea, Republic of, South Africa, Taiwan, Argentina, Brazil, Austria, Russian Federation, Australia, Armenia, Greece, Tunisia
-
AllerganCompletedMacular DegenerationSpain, United States, Korea, Republic of, Israel, Singapore, Argentina, Germany, France, Czechia, Austria, Philippines, Switzerland, Chile, Colombia, Hong Kong, Latvia, New Zealand
-
XOMA (US) LLCInstitut de Recherches Internationales ServierTerminatedUveitisUnited States, France, Germany, Poland, United Kingdom, China, Spain, Mexico, Portugal, Turkey, Israel, Canada, South Africa, Taiwan, Argentina, Russian Federation, Australia, Italy, Brazil, Armenia, Greece, Tunisia
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Romania, United States, Japan, Russian Federation, Spain, Canada, Germany, Latvia, Mexico, Brazil
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Norway, Belgium, Hungary, Slovakia, Taiwan, Philippines, Thailand, Mexico, Hong Kong, Malaysia
-
xCuresCancer CommonsAvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesMelanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditionsUnited States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Hong Kong, Israel, New Zealand, Ukraine
-
Novo Nordisk A/SCompleted
-
Institute of Tropical Medicine, BelgiumMemisa, BelgiumActive, not recruitingDiabetes Mellitus, Type 2 | Gestational DiabetesCongo, The Democratic Republic of the